Does Sanofi (SNY) Have a Long Runway for Future Growth?

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Select Fund” fourth-quarter 2025 investor letter. It is a non-diversified fund that focuses on long-term capital appreciation by investing in common stocks of U.S. and non-U.S. companies. A copy of the letter can be downloaded here. In the fourth quarter, the fund (Investor Class) delivered a return of 2.91%, lagging behind the benchmark, the MSCI World Index’s 3.12% gain. Healthcare and financials were the top performance contributors at the sector level, while the consumer discretionary and consumer staples...